XIE Xiaofeng, BAI Xue, LAN Xiaofeng, LI Muli, DU Caiwen. Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 1029-1034. DOI: 10.3971/j.issn.1000-8578.2023.23.0430
Citation:
|
XIE Xiaofeng, BAI Xue, LAN Xiaofeng, LI Muli, DU Caiwen. Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 1029-1034. DOI: 10.3971/j.issn.1000-8578.2023.23.0430
|
XIE Xiaofeng, BAI Xue, LAN Xiaofeng, LI Muli, DU Caiwen. Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 1029-1034. DOI: 10.3971/j.issn.1000-8578.2023.23.0430
Citation:
|
XIE Xiaofeng, BAI Xue, LAN Xiaofeng, LI Muli, DU Caiwen. Inetetamab Treatment for Liver Oligometastases of HER2-Positive Breast Cancer: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 1029-1034. DOI: 10.3971/j.issn.1000-8578.2023.23.0430
|